|
|
| SN |
Author |
Title |
Status |
| 451 |
Ishwarya |
EXPLORING THE MOLECULAR BASIS AND SUSCEPTIBILITY PATTERNS OF CARBAPENEM-RESISTANT BACTERIA
|
Accepted |
| 452 |
Sharda |
FORMULATION AND EVALUATION OF POLYHERBAL LACTATION TABLET OF MORINGA |
Under Review |
| 453 |
Sakshi |
BIOACTIVE CONSTITUENTS AND PHARMACOLOGICAL ACTIVITIES OF MULBERRY (MORUS SPP.) FRUIT: A REVIEW |
Under Review |
| 454 |
VANDANA |
MADHUMEHA (DIABETES MELLITUS) IN AYURVEDIC LITERATURE: A REVIEW |
Accepted |
| 455 |
Abhishek C |
EVALUATION OF INVITRO ANTIDIABETIC ACTIVITY OF SOME NOVEL SYNTHESIZED 2(5'- SUBSTITUTED PHENYL 1', 3’, 4’ OXADIAZOL-2'-YL) AMINO-6-FLUORO-7-SUBSTITUTED (1, 3)-BENZOTHIAZOLES DERIVATIVES |
Accepted |
| 456 |
Shruti |
ASHWAGANDHA : AN EXTENSIVE REVIEW OF ASHWAGANDHA’S CHEMICAL CONSTITUENTS, BIOLOGICAL ACTIVITIES, AND THERAPEUTIC APPLICATIONS |
Accepted |
| 457 |
Md Aamir Hussain |
DESIGN, CHARACTERIZATION AND IN-VITRO EVALUATION OF A NOVEL BILAYERTABLET COMBINING IMMEDIATE-RELEASE AZITHROMYCIN(WITHSUPERDISINTEGRANT VIA SLUGGING METHOD ) AND SUSTAINED-RELEASE LEVOFLOXACIN(WITH H |
Accepted |
| 458 |
Pallavi Ankush |
FORMULATION, EVALUATION, AND PHARMACOLOGICAL POTENTIAL OF ACHYRANTHUS ASPERA BASED – HERBAL POWDER |
Under Review |
| 459 |
Vidhya Vaijinath |
FORMULATION AND EVALUATION OF TRIDAX PROCUMBENS LEAVES-BASED THERMO SENSITIVE IN-SITU NASAL GEL FOR ASTHMA THERAPY.
|
Under Review |
| 460 |
Vidhya Vaijinath |
FORMULATION AND EVALUATION OF TRIDAX PROCUMBENS LEAVES-BASED THERMO SENSITIVE IN-SITU NASAL GEL FOR ASTHMA THERAPY.
|
Under Review |
| 461 |
sandesh |
ARTICLE ON NANOPARTICLE |
Accepted |
| 462 |
sandesh |
ARTICLE ON NANOPARTICLES |
Under Review |
| 463 |
Aaditya |
OCCUPATIONAL AND ENVIRONMENTAL HEALTH HAZARDS OF EMBALMING FLUIDS: A SYSTEMATIC REVIEW OF EXPOSURE, RISKS AND MITIGATION STRATEGIES |
Accepted |
| 464 |
Sushil Kr. Mehta |
A REVIEW ON FORMULATION AND EVALUATION OF HERBAL TOOTHPASTE : A NATURAL APPROACH TO ORAL HYGIENE |
Accepted |
| 465 |
KURUVA CHANDRA |
ANALYTICAL METHOD DEVELOPMENT AND VALIDATION FOR THE DETERMINATION OF LEVETIRACETAM IN API BY USING RP-HPLC * |
Accepted |
| 466 |
komal |
COMBINATION AND RESISTANCE THERAPY IN LUNG CANCER |
Accepted |
| 467 |
Rahevar |
FORMULATION AND EVALUATION OF POLYHERBAL EMULGEL ON WOUND HEALING ACTIVITY |
Accepted |
| 468 |
Mahammad Noorulla |
DEVELOPMENT AND VALIDATION OF A STABILITY-INDICATING RP-HPLC METHOD FOR SIMULTANEOUS ESTIMATION OF VANZACAFTOR, TEZACAFTOR, AND DEUTIVACAFTOR IN PHARMACEUTICAL FORMULATION |
Under Review |
| 469 |
Shruti |
ASHWAGANDHA : AN EXTENSIVE REVIEW OF ASHWAGANDHA’S CHEMICAL CONSTITUENTS, BIOLOGICAL ACTIVITIES, AND THERAPEUTIC APPLICATIONS |
Accepted |
| 470 |
Shruti |
ASHWAGANDHA : AN EXTENSIVE REVIEW OF ASHWAGANDHA’S CHEMICAL CONSTITUENTS, BIOLOGICAL ACTIVITIES, AND THERAPEUTIC APPLICATIONS |
Under Review |
| 471 |
Yogesh |
RECENT ADVANCEMENT IN USE OF COMPUTERS IN PHARMACEUTICAL FORMULATION DEVELOPMENT. |
Accepted |
| 472 |
Yogesh |
A REVIEW ON COSMETIC SCIENCE FOR SKIN |
Accepted |
| 473 |
Satyam Kumar |
PHARMACOVIGILANCE IN THE 21ST CENTURY: METHODS, CHALLENGES, AND THE IMPACT OF REAL-WORLD DATA AND ARTIFICIAL INTELLIGENCE |
Accepted |
| 474 |
Yogesh |
THE ROLE OF ARTIFICIAL INTELLIGENCE IN FUTURE PHARMACY EDUCATION |
Accepted |
| 475 |
Rakshitha |
TITLE: “PHYTOCHEMICAL AND ANALYTICAL PROFILING OF SUKHA PRASAVA NABHI LEPA: INTEGRATING TRADITIONAL INSIGHTS WITH MODERN ANALYTICAL TOOLS” |
Under Review |
| 476 |
Rakshitha |
“INNOVATION THROUGH TRADITION: PHARMACEUTICAL STANDARDIZATION OF SUKHA PRASAVA NABHI LEPA AND ITS TOPICAL PATCH” |
Accepted |
| 477 |
Sova |
“THERAPEUTIC APPLICCATIONS OF CRISPR – CAS 9: CURRENT PROSPECTS AND CHALLENGES.” |
Under Review |
| 478 |
161-Patil |
QUALITY BY DESIGN APPROACHES (QBD) IN THE DEVELOPMENT OF HYDROGEL-BASED DRUG DELIVERY SYSTEMS |
Accepted |
| 479 |
Karan S. Waghmode |
OVERVIEW OF GREEN CHEMISTRY AND SUSTAINABLE FUTURE |
Under Review |
| 480 |
Prashant |
“FROM BENCH TO BESIDE: A COMPREHENSION REVIEW OF
CAR – T CELL THERAPY”
|
Accepted |
| 481 |
Aditya |
“A DETAILED REVIEW OF THE BLACK JAVA PLUM ’’ |
Under Review |
| 482 |
Pendyala |
PROTEOLYSIS TARGETING CHIMERAS (PROTACS): MECHANISMS, DESIGN STRATEGIES, AND THERAPEUTIC APPLICATIONS |
Under Review |
| 483 |
Geetesh |
"ANALYTICAL QUALITY BY DESIGN APPROACH FOR HPLC METHOD DEVELOPMENT AND VALIDATION OF TOFACITINIB CITRATE IN PHARMACEUTICAL FORMULATIONS” |
Accepted |
| 484 |
Geetesh |
"ANALYTICAL QUALITY BY DESIGN APPROACH FOR HPLC METHOD DEVELOPMENT AND VALIDATION OF TOFACITINIB CITRATE IN PHARMACEUTICAL FORMULATIONS" |
Under Review |
| 485 |
Sravanasree Buddha |
PHARMACOGENOMICS IN CLINICAL PRACTICE: CURRENT APPLICATIONS AND FUTURE PROSPECTS |
Accepted |
| 486 |
Srushti |
PHYTOCHEMICAL STUDY OF MEDICINAL PLANS |
Under Review |
| 487 |
Yogesh |
RECENT ADVANCEMENTSIN NANOTECHNOLOGY BASED DRUG DELIVERY FOR THE MANAGEMENT OF CARDIOVASCULAR DISEASE |
Accepted |
| 488 |
Varad |
Advances in Computer-Aided Drug Design: From Molecular Modeling to Lead Optimization
|
Under Review |
| 489 |
Varad |
Advances in Computer-Aided Drug Design: From Molecular Modeling to Lead Optimization
|
Under Review |
| 490 |
Varad |
Advances in Computer-Aided Drug Design: From Molecular Modeling to Lead Optimization
|
Under Review |
| 491 |
Ruwan Priyantha |
NICOTINE DE-ADDICTION THROUGH AYURVEDA AND BUDDHIST PSYCHOTHERAPY: A CASE REPORT ON INTEGRATED TREATMENT |
Accepted |
| 492 |
Vaishnavi |
A REVIEW ON FLAXSEED AS A HAIR SMOOTHENING AGENT |
Accepted |
| 493 |
Pinal |
“EXPLORING STHAULYA THROUGH AYURVEDIC LITERATURE: A COMPREHENSIVE REVIEW” |
Under Review |
| 494 |
Nazia Mahveen Khan |
FORMULATION AND IN VITRO EVALUATION OF ETHOSOMAL TRANSDERMAL PATCH OF IRBESARTAN |
Under Review |
| 495 |
ARCHANA |
RESEARCH ARTICLE |
Accepted |
| 496 |
ARCHANA |
RESEARCH ARTICLE |
Under Review |
| 497 |
sakshi |
COMPREHENSIVE REVIEW ON CURRENT APPROACHES TO FUNGAL DISEASE |
Accepted |
| 498 |
sakshi |
COMPREHENSIVE REVIEW ON CURRENT APPROACHES TO FUNGAL DISEASE |
Under Review |
| 499 |
Dipti |
BOOK REVIEW : PRACTICAL DIABETES MELLITUS |
Accepted |
| 500 |
Varad |
COMPUTER AIDED DRUG DESIGN AND DRUG DISCOVERY. |
Accepted |
|
|
